-
Table of Contents
- Metabolites of Drostanolone Propionato and Their Activity
- Metabolism of Drostanolone Propionato
- 5α-Dihydrodrostanolone
- 2α-Methyl-5α-androstan-3α-ol-17-one
- 2α-Methyl-5α-androstan-3α,17β-diol
- 2α-Methyl-5α-androstan-3α,17β-diol-3-glucuronide
- 2α-Methyl-5α-androstan-3α,17β-diol-3-sulfate
- Pharmacological Activity of Metabolites
Metabolites of Drostanolone Propionato and Their Activity
Drostanolone propionato, also known as Masteron, is a synthetic anabolic androgenic steroid (AAS) that has been used in the field of sports pharmacology for its performance-enhancing effects. It is a derivative of dihydrotestosterone (DHT) and is commonly used by bodybuilders and athletes to improve muscle mass, strength, and overall physical performance. However, like other AAS, drostanolone propionato is known to undergo metabolism in the body, resulting in the formation of various metabolites that can have different effects on the body. In this article, we will explore the different metabolites of drostanolone propionato and their activity, providing a comprehensive understanding of this widely used AAS.
Metabolism of Drostanolone Propionato
Before delving into the specific metabolites of drostanolone propionato, it is important to understand its metabolism in the body. Like other AAS, drostanolone propionato is metabolized primarily in the liver, where it undergoes various chemical reactions to form different metabolites. These metabolites are then excreted from the body through urine and feces. The metabolism of drostanolone propionato involves both phase I and phase II reactions, which are essential for the conversion of the parent compound into its active and inactive metabolites.
Phase I reactions involve the oxidation, reduction, and hydrolysis of the parent compound, resulting in the formation of various metabolites. These metabolites are then further metabolized through phase II reactions, which involve conjugation with glucuronic acid, sulfate, or glutathione. This process makes the metabolites more water-soluble and easier to excrete from the body. The specific metabolites formed during the metabolism of drostanolone propionato will now be discussed in detail.
5α-Dihydrodrostanolone
5α-Dihydrodrostanolone, also known as Dihydrotestosterone (DHT), is the primary metabolite of drostanolone propionato. It is formed through the reduction of the 5α-double bond in the A-ring of drostanolone propionato. DHT is a potent androgen that binds to and activates the androgen receptor, resulting in anabolic effects such as increased muscle mass and strength. However, it also has androgenic effects, which can lead to side effects such as acne, hair loss, and prostate enlargement. DHT is also known to have a higher affinity for the androgen receptor compared to testosterone, making it a more potent androgen.
2α-Methyl-5α-androstan-3α-ol-17-one
2α-Methyl-5α-androstan-3α-ol-17-one, also known as 2α-methyl-DHT, is another metabolite of drostanolone propionato. It is formed through the reduction of the 3-keto group in the A-ring of drostanolone propionato. This metabolite has similar androgenic effects to DHT but is less potent. It also has a higher affinity for the androgen receptor compared to testosterone, making it a more potent androgen. However, it is less potent than DHT, which may result in a lower risk of androgenic side effects.
2α-Methyl-5α-androstan-3α,17β-diol
2α-Methyl-5α-androstan-3α,17β-diol, also known as 2α-methyl-5α-androstane-3α,17β-diol, is a metabolite of drostanolone propionato formed through the reduction of the 17-keto group in the D-ring. This metabolite has both anabolic and androgenic effects, but its potency is lower compared to DHT and 2α-methyl-DHT. It also has a higher affinity for the androgen receptor compared to testosterone, making it a more potent androgen. However, its lower potency may result in a lower risk of androgenic side effects.
2α-Methyl-5α-androstan-3α,17β-diol-3-glucuronide
2α-Methyl-5α-androstan-3α,17β-diol-3-glucuronide is a conjugated metabolite of drostanolone propionato formed through the addition of glucuronic acid to the 3-hydroxyl group of 2α-methyl-5α-androstan-3α,17β-diol. This metabolite is inactive and is excreted from the body through urine. It is the primary metabolite found in urine after the administration of drostanolone propionato, making it a useful marker for detecting its use in doping control.
2α-Methyl-5α-androstan-3α,17β-diol-3-sulfate
2α-Methyl-5α-androstan-3α,17β-diol-3-sulfate is another conjugated metabolite of drostanolone propionato formed through the addition of sulfate to the 3-hydroxyl group of 2α-methyl-5α-androstan-3α,17β-diol. This metabolite is also inactive and is excreted from the body through urine. It is a minor metabolite compared to 2α-methyl-5α-androstan-3α,17β-diol-3-glucuronide, but its presence in urine can also indicate the use of drostanolone propionato.
Pharmacological Activity of Metabolites
The different metabolites of drostanolone propionato have varying pharmacological activity, which can have different effects on the body. DHT, being the primary metabolite, has the most potent androgenic effects, which can lead to increased muscle mass and strength. However, it also has a higher risk of androgenic side effects, which may be undesirable for some users. 2α-methyl-DHT and 2α-methyl-5α-androstan-3α,17β-diol have similar androgenic effects to DHT but are less potent, which may result in a lower risk of side effects.
On the other hand, 2α-methyl-5α-androstan-3α,17β-diol-3-glucuronide and 2α-methyl-5α-androstan-3α,17β-diol-3-sulfate are inactive metabolites that are excreted from the body. These metabolites do not have any pharmacological activity and do not contribute to the anabolic or androgenic effects of